Home > Our Approach > Our Services
Wellmera understands the key issues facing our clients. We have the insight and experience to assist our clients at every stage of a product’s lifecycle.
-
Market Access, Pricing and Reimbursement Strategies
- Conduct P&R landscape assessments
- Develop market access strategies
- Develop pricing and reimbursement strategies and dossiers
- Design and facilitate pricing and reimbursement workshops with cross-functional and international teams
- Conduct pricing risk assessments
-
Payer Evidence Plans
- Generate integrated payer evidence and analysis plans to support pricing, reimbursement, and market access
- Prepare and facilitate international payer advisory boards to optimize development programs, and gather insights on product value and evidence requirements
- Design and facilitate product value workshops with cross-functional and international teams
- Conduct payer/HTA landscape assessments
-
Health Economic and Outcomes Research Support
- Develop HEOR and evidence strategies
- Provide expert review of global cost-effectiveness models and country adaptations
- Develop budget impact and cost-effectiveness models
- Develop PRO strategies
- Conduct competitor analyses
-
Real-World Evidence Support
- Provide expert input into the design and analysis of real-world studies
- Define publication strategies
- Develop manuscripts and study reports
- Conduct systematic literature reviews
- Manage external database owners and programmers
- Advise on data extraction, data analysis, and data specification documents (e.g. protocols and study reports)
-
Value Communications
- Develop and test evidence-based value propositions and messages
- Conduct primary research with KOLs and payers
- Prepare briefing books for national consultations and payer advisory boards
- Develop GVDs, value stories, and objection handlers
- Write publications
- Prepare regional adaptations of HTA/P&R submissions
- Provide expert input into advisory boards/discussion panels
-
Medical Devices, Diagnostics, and Digital Health
- Define EU public and private access pathways (e.g. reimbursement coding, payment infrastructures, stakeholders involved, etc.)
- Identify evidence required for reimbursement and HTA assessment in Europe
- Develop and refine value messages and payer value propositions (analytical validity, clinical validity, and clinical utility) to meet the needs of specific European markets
- Adapt market access strategies for specific stakeholder archetypes
- Conduct pricing surveys to determine payers’ willingness-to-pay
- Develop evidence- or value-based payment schemes
- Recommend innovative pricing schemes
- Build innovative early access programs